Skip To Main Content
This website is intended exclusively for healthcare professionals residing and/or working in the UAE.
Campus
  • Payor
Campus
  • Payor

Science at Sanofi

Discover a wide variety of articles, videos, podcasts, accredited courses, applications, conferences and scientific events in different therapeutic areas

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content
The role of the patient in Achieving LDL-C Target

The role of the patient in Achieving LDL-C Target

Learn more
Identifying and treating patients with high Lipidaemia risk post-ACS

Identifying and treating patients with high Lipidaemia risk post-ACS

Watch Prof. Pasquale Perrone-Filardi from Department of Clinical Medicine, Cardiovascular and Immunology Sciences, Federico II University, Naples sharing insights on Identifying and treating patients with high lipidaemia risk post-ACS.

Learn more
Effect of Alirocumab on MACE in patients with CKD

Effect of Alirocumab on MACE in patients with CKD

Learn more
Lipid management in patients with ACS/ASCVD

Lipid management in patients with ACS/ASCVD

Learn more
In hospital outcomes in young patients with AMI: Results from Gulf Coast

In hospital outcomes in young patients with AMI: Results from Gulf Coast

Learn more
Adherence and persistence analysis in patients treated with DAPT

Adherence and persistence analysis in patients treated with DAPT

Learn more
Effect of de-escalated P2Y12 inhibitor switching in dual antiplatelet therapy (DAPT)

Effect of de-escalated P2Y12 inhibitor switching in dual antiplatelet therapy (DAPT)

Learn more
Is Clopidogrel a viable first choice P2Y12 inhibitor for DAPT after PCI?

Is Clopidogrel a viable first choice P2Y12 inhibitor for DAPT after PCI?

Learn more
Burden of Disease

Burden of Disease

Learn more
DAPT in Elderly with CAD Meta Analysis

DAPT in Elderly with CAD Meta Analysis

Watch the video and get to know more on the crucial insights from this systematic review and meta-analysis of DAPT in elderly patients with acute coronary syndrome (ACS). Dual oral antiplatelet therapy (DAPT) with prasugrel or ticagrelor is associated with a higher risk of bleeding events in elderly patients with ACS compared to clopidogrel, with no difference in primary efficacy endpoint rates between the treatment groups.

Learn more
Effectiveness and safety of Clopidogrel vs Aspirin

Effectiveness and safety of Clopidogrel vs Aspirin

Learn more
Single Antiplatelet therapy: Insights on earlier use

Single Antiplatelet therapy: Insights on earlier use

Learn more